Our transcriptomic analysis identified several highly expressed CAF-associated genes, including PDPN, PRSS3, GREM1, and LGALS1, that represent either directly druggable targets or components of clinically actionable pathways, and we evaluated their relevance to the PCa stromal phenotype. This evidence concerns the gene GREM1 and posterior cortical atrophy.